Related Tags >> FDA Merck Vioxx pharmaceuticals

heart disease News

Most Popular heart disease Story

Pioneering stem cell therapy mends damaged heart tissue in patients

February 14, 2012 — 8:09am ET | By Ryan McBride

Score one small victory for the troubled field of stem cell therapeutics. A small clinical trial showed that patients' own stem cells could repair damaged heart tissue after they suffered heart Read more...

heart disease Press Releases

Aviir in Conjunction with Guard A Heart Foundation Presenting Award to Larry King on February 25th in Recognition of
KineMed Announces Research Collaboration With Pfizer for the Advancement of Novel Approaches in Metabolic Disease
The microbiome and disease: Gut bacteria influence the severity of heart attacks in rats
Aviir Announces Agreement to Raise up to $30 Million in Latest Financing Round
Abbott Initiates Clinical Trial to Evaluate the Absorb™ Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Sten

Latest Headlines

Pioneering stem cell therapy mends damaged heart tissue in patients
February 14, 2012
Amgen drug shows it can 'improve heart function' in Ph2
August 19, 2011
South Korean biotech wins OK for stem cell treatment
July 7, 2011
Merck's heart drug flunks Phase III trial
June 5, 2009
ALSO NOTED: Researchers testing stem cell therapy for CHF; Boehringer unveils new research center; and much more...
May 27, 2008
FDA's delay of Geron ESC trial raises concerns
May 15, 2008
BMS inks $227M collaboration deal with KAI
May 13, 2008
Cholesterol drug delay signals new FDA standards
April 28, 2008
Genzyme gets biosimilar rejection, builds R&D plant
April 22, 2008
Trial delay forces Vasogen to hack 85% of staff
April 14, 2008
ALSO NOTED: PDL offers bonuses to top execs; Radius earns $28.3M for milestone;Cytokinetics surges on positive data; and much m
April 2, 2008
Clinical trial data disappears in NIH laptop heist
March 24, 2008
SPOTLIGHT: Stem cell trial approved
February 27, 2008
ALSO NOTED: ZymoGenetics to chop jobs; Evotec extends collaboration; Iomai touts results for vaccine patch; and much more...
February 14, 2008
GSK, Adolor face another Entereg delay
February 11, 2008
PDL sells off drugs as it counters harsh criticism
February 5, 2008
Teva snaps up CoGenesys in $400M buyout
January 22, 2008
ALSO NOTED: Agennix OK'd to launch late-stage lung cancer trial; QLT reorganizes; Ventana still resisting Roche bid; and much m
January 17, 2008
VC: Genizon rounds up $31M
January 10, 2008
deCODE touts heart attack prevention study
January 9, 2008

Paid Research Reports

More Research Reports >>

Free Newsletter

Most Popular Stories

Webinars

Hottest Products

Featured Jobs

Events